Search

Displaying all 5 results
DrugBest match

Cabotegravir

go.drugbank.com/drugs/DB11751
ApprovedInvestigational

Cabotegravir, or GSK1265744, is an HIV-1 integrase inhibitor that is prescribed with the non-nucleoside reverse transcriptase inhibitor, rilpivirine. Early research into cabotegravir showed it had lower oral bioavailability than dolutegravir, which resulted in the development of long acting monthly intramuscular inj...

  1. Pathway

    Cabotegravir Action Pathway

    smpdb.ca/view/SMP0125914
    Drug action

    Cabotegravir is an HIV-1 integrase inhibitor used for treatment and pre-exposure prophylaxis of HIV-1 infection. … Cabotegravir is transported into the infected cell then transported into the nucleus via importin nuclear transporter.

    Drugs: Cabotegravir
  2. Drug

    Rilpivirine

    go.drugbank.com/drugs/DB08864
    ApprovedInvestigational

    [L1031] Rilpivirine in combination with [cabotegravir] was granted FDA approval on 21 January 2021.

  3. Indication

    Human Immunodeficiency Virus Type 1 (HIV-1)

    go.drugbank.com/conditions/DBCOND0042885
    Drugs: Cabotegravir · Doravirine · Enfuvirtide · Rilpivirine
  4. Indication

    Human Immunodeficiency Virus Type 1 (HIV-1) Infection

    go.drugbank.com/conditions/DBCOND0045921
    Drugs: Abacavir · Atazanavir · Bictegravir · Cabotegravir · Cobicistat · Darunavir +25 more